Details checkedClinical trial listing onlyCheckedregistry

Jessa DFNA9 Vestibulopathy Imaging and Genetics Study

Also known as: p.P51S mutation, COCH p.P51S mutation, DFNA9, Correlation of Radiological Lesions With Vestibular Function in Patients With Bilateral Vestibulopathy, NCT04070937

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Diagnostic

Modality

Diagnostic

Stage

Observational/NA

Status

Active

Target Gene

COCH

Route / Mode

Diagnostic testing and genetic analysis

Confidence

84%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

Belgium

Population

adult, genetic, vestibular, sensorineural

Trial IDs

Mechanism

Observational diagnostic and genetic study correlating radiologic temporal-bone lesions, vestibular testing, audiometry, and COCH p.P51S mutation status in bilateral vestibulopathy/DFNA9.

Indications

Hearing Loss Sensorineural Hearing Loss Genetic Hearing Loss

Notes

Corrected from a misleading gene-therapy therapeutic row to an observational diagnostic/genetic study. The registry lists p.P51S mutation analysis as a genetic assessment, not a treatment intervention.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, aliases, company, allCompanies, isIndustrySponsored, programType, modality, mechanism...

IDs: NCT04070937

Open

Key Events

2019-09-01

Registry lists actual study start for Jessa DFNA9 vestibulopathy imaging and genetics study

Clinical Trials (1)

NCT04070937

Data Checks